MedPath

To compare fentanyl and ketamine as pain relief agent in preterm babies requiring laser treatment for retinopathy of prematurity(ROP)

Phase 2
Completed
Conditions
Health Condition 1: null- Retinopathy of prematurity
Registration Number
CTRI/2018/03/012878
Lead Sponsor
Division of Neonatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
124
Inclusion Criteria

All preterm infants attending clinic at RP Center for laser therapy for ROP

a)Declared fit for undergoing laser therapy

b)Anticipated duration of procedure > 30 minutes

c)Hemodynamically stable

d)No anemia( PCV >30)

e)Absence of major morbidities [Grade III-IV intraventricular hemorrhage(IVH), (patent ductus arteriosus(PDA), necrotizing enterocolitis(NEC)]

Exclusion Criteria

a)Babies with congenital malformations

b)Babies already on CPAP, MV or sick enough to require NICU care

c)Babies with hypertension

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath